Research Roundup: The Latest Science, Discoveries, And Breakthroughs
Each week, KFF Health News compiles a selection of health policy studies and briefs.
MedPage Today:
GLP-1 Drugs May Benefit Cancer Patients With Brain Lesions
GLP-1 receptor agonist use was associated with a lower risk of death in cancer patients with brain metastases and type 2 diabetes, a retrospective cohort study found. (Monaco, 3/11)
MedPage Today:
Some Cancers May Be Slightly Elevated In Women Who've Had Fertility Treatment
While overall cancer incidence among women who used medically assisted reproduction wasn't elevated, certain cancers were more common in this population, an Australian population-based cohort study showed. (Robertson, 3/10)
MedPage Today:
Sentinel Node Biopsy Improves Survival In Melanoma, Meta-Analysis Shows
Sentinel node biopsy (SNB) significantly reduced the risk of death from melanoma, results from a systematic review and meta-analysis indicated. (Bassett, 3/9)
Bloomberg:
Roche Breast-Cancer Drug Combination Misses Target In Study
A Roche Holding AG study of its experimental breast-cancer drug in combination with another treatment failed to meet the main goal, a blow to the company’s effort to develop a next-generation hormone therapy that sent its shares lower. Patients treated with Roche’s giredestrant and an older drug developed by Pfizer Inc. were no more likely to live without their cancer worsening than those given standard therapy, the Swiss drugmaker said Monday. (Kinzelmann, 3/9)
MedPage Today:
Incidence Of Bowel Disease In Kids Nearly Quadrupled Over 40 Years
Incidence of pediatric inflammatory bowel disease (IBD) in one region of Denmark nearly quadrupled over four decades, according to a new population-based cohort study. (McCreary, 3/5)
